Business Wire
21 Nov 2026, 23:14 UTC · 5h ago
NRIX Investors Have Opportunity to Join Nurix Therapeutics, Inc. Fraud Investigation with SBS Law
Impact · against what's priced in
The initiation of a fraud investigation by SBS Law introduces new legal risk for Nurix Therapeutics. This development potentially threatens valuation multiples and institutional confidence as the market assesses the legitimacy of the claims.
- NRIX−0.40
No priced-in read yet





